The quality of laboratory aspects of troponin testing in clinical practice guidelines and consensus documents needs to be improved

Clinica Chimica Acta

Volumn 437, Issue , 2014, Pages 58-61

  Aakre, Kristin M ^a,b,c   Langlois, Michel R ^c,d   Barth, Julian H ^c,e   Misra, Shivani ^c,f   Watine, Joseph ^c,g   Oosterhuis, Wytze P ^c,h  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b Norwegian Clinical Chemistry EQA Program   (Norway)

^c European Federation of Clinical Chemistry and Laboratory Medicine   (Netherlands)

^d General Hospital St Jan   (Belgium)

^e LEEDS GENERAL INFIRMARY   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

^g Laboratoire de Biologie Polyvalente   (France)

^h Zuyderland Medical Centre   (Netherlands)

Author keywords

Acute coronary syndrome; Analytical quality; Guideline; Interference; Troponin

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; ARTICLE; CONSENSUS; CONTROLLED STUDY; DISEASE MARKER; DOCUMENTATION; FALSE POSITIVE RESULT; HUMAN; LABORATORY TEST; MEDICAL SERVICE; MEDICAL SOCIETY; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN DETERMINATION; PUBLICATION; QUALITY CONTROL; SENSITIVITY ANALYSIS; BLOOD; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; STANDARDS; TRENDS;

CLINICAL LABORATORY TECHNIQUES; CONSENSUS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; TROPONIN;

EID: 84904760002     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.07.006     Document Type: Article

References (27)

1. Aakre K.M., Langlois M.R., Watine J., et al. Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation. Clin Chem Lab Med 2013, 51:1217-1226.
2. Thygesen K., Alpert J.S., Jaffe A.S., et al. Third universal definition of myocardial infarction. Eur Heart J 2012, 33:2551-2567.
3. Collinson P.O., van Dieijen-Visser M.P., Pulkki K., et al. Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study. Clin Chem 2012, 58:305-306.
4. Thygesen K., Mair J., Giannitsis E., et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012, 33:2252-2257.
5. Newby L.K., Jesse R.L., Babb J.D., et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2012, 60:2427-2463.
6. Chew D.P., Aroney C.N., Aylward P.E., et al. 2011 Addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006. Heart Lung Circ 2011, 20:487-502.
7. Davis T, Bluhm J, Burke R, et al. Diagnosis and Treatment of Chest Pain and Acute Coronary Syndrome (ACS). Institute for Clinical Systems Improvement. Updated November 2012. Accessed June 2014; 2012. https://www.icsi.org/_asset/ydv4b3/ACS-Interactive1112b.pdf.
8. NICE clinical guideline 95: Chest pain of recent onset Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin 2010, National Institute for Health and Clinical Excellence, [Accessed June 2014. http://www.nice.org.uk/guidance/CG95].
9. Hamm C.W., Bassand J.P., Agewall S., et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011, 32:2999-3054.
10. SIGN 93. Acute coronary syndromes. A national clinical guideline. Scottish Intercollegiate Guidelines Network; 2013. Updated February 2013. Accessed June 2014. www.sign.ac.uk.
11. Task Force on the management of STseamiotESoC, Steg P.G., James S.K., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33:2569-2619.
12. Bais R. The effect of sample hemolysis on cardiac troponin I and T assays. Clin Chem 2010, 56:1357-1359.
13. Lippi G., Aloe R., Meschi T., Borghi L., Cervellin G. Interference from heterophilic antibodies in troponin testing. Case report and systematic review of the literature. Clin Chim Acta 2013, 426:79-84.
14. Saenger A.K., Beyrau R., Braun S., et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011, 412:748-754.
15. Burness C.E., Beacock D., Channer K.S. Pitfalls and problems of relying on serum troponin. QJM 2005, 98:365-371.
16. Mingels A., Jacobs L., Michielsen E., Swaanenburg J., Wodzig W., van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009, 55:101-108.
17. Fraser C.G., Kallner A., Kenny D., Petersen P.H. Introduction: strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999, 59:477-478.
18. Fraser C.G., Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989, 27:409-437.
19. Nordenskjold A.M., Ahlstrom H., Eggers K.M., et al. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem 2013, 59:401-409.
20. Dupuy A.M., Lozano C., Badiou S., Bargnoux A.S., Kuster N., Cristol J.P. Biological variability of hs-cardiac troponin T on the Roche Cobas 8000/e602(R) immunoanalyzer. Clin Chim Acta 2013, 425C:62-63.
21. Aakre K.M., Roraas T., Petersen P.H., et al. Weekly and 90-minute biological variations in cardiac troponin T and cardiac Troponin I in hemodialysis patients and healthy controls. Clin Chem 2014, 60:838-847.
22. Hammarsten O., Jacobsson C.E., Widegren M., Danylchenko T., Jaffe A.S. Long-time quality assessment of the Elecsys Troponin T hs assay. Clin Biochem 2013, 46:1055-1057.
23. Apple F.S., Jaffe A.S. Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: user beware. Clin Chem 2012, 58:1599-1600.
24. Gowans E.M., Hyltoft Petersen P., Blaabjerg O., Horder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988, 48:757-764.
25. Savukoski T., Twarda A., Hellberg S., et al. Epitope specificity and IgG subclass distribution of autoantibodies to cardiac troponin. Clin Chem 2013, 59:512-518.
26. Vafaie M., Biener M., Mueller M., et al. Analytically false or true positive elevations of high sensitivity cardiac troponin: a systematic approach. Heart 2014, 100:508-514.
27. Legendre-Bazydlo L.A., Haverstick D.M., Kennedy J.L., Dent J.M., Bruns D.E. Persistent increase of cardiac troponin I in plasma without evidence of cardiac injury. Clin Chem 2010, 56:702-705.